fda changes semaglutide Semaglutide: The Drug of Today and a Steppingstone to Tomorrow Semaglutide Before And After with

New research is also giving us a clearer understanding of how GLP-1s could affect cardiovascular outcomes in specific populations, such as those with known heart disease or certain types of heart failure

The potential role of GLP-1 receptor agonists as conservative treatment for endometrial cancer in reproductive-aged women: a review and call for study

Estradiol in vivo regulation of brain mitochondrial proteome

There is no proof so far that ties ibuprofen to a higher risk of pancreatitis when taken with tirzepatide

Results of the ESSENCE Trial Results from the ESSENCE trials after 72 weeks of treatment found 62.9% of participants experienced a reduction in steatohepatitis (inflammation of the liver with fat accumulation in the liver) versus 34.3% for participants who took the placebo